Skip to main content
. 2024 Mar 4;16(1):2323231. doi: 10.1080/19490976.2024.2323231

Figure 2.

Figure 2.

Alterations of gut microbial structures in IBD. (a) PCoA of IBD-Act, IBD-Rem, and HC based on Bray-Curtis dissimilarity metrics, with statistical significance and variance of dissimilarity data assessed using ANOSIM. (b) Correlations between PC1 of microbiota and DAI (PCDAI/PUCAI: n = 70; fecal calprotectin: n = 58) in all IBD patients, as analyzed by Pearson correlation. (c) Average relative proportions of the main phyla and genera in the three groups. The significantly increased phylum in active-phase patients is mainly Proteobacteria, while the significantly decreased phylum is mainly Bacteroidota. (d) LEfSe used to identify essential differences in bacterial abundance (from phylum to genus levels) between IBD-Act and IBD-Rem (LDA threshold > 4.0). Differentially abundant microbial species are highlighted using red and blue boxes in panels D, with red indicating an increase in active IBD and blue indicating a decrease in active IBD. (e) Heatmap of Spearman’s correlation between IBD severity-related microbial taxa and DAI; *p < .05, **p < .01, ***p < .001).